Literature DB >> 20022961

Investigation of human telomerase holoenzyme assembly, activity, and processivity using disease-linked subunit variants.

Aaron R Robart1, Kathleen Collins.   

Abstract

After the initial discovery of human telomerase deficiency in the X-linked form of the bone marrow failure syndrome dyskeratosis congenita, mutations in genes encoding telomerase subunits have been identified in patients with a wide spectrum of disorders. Structure/function studies of disease-linked variants of human telomerase RNA (hTR) or telomerase reverse transcriptase (TERT) have exploited in vitro reconstitution of the enzyme catalytic core and/or a PCR-amplified activity assay readout that would not reflect alterations of cellular RNP assembly efficiency, telomeric primer recognition, and/or repeat addition processivity. Here we used telomerase reconstitution in vivo and direct telomeric-repeat primer extension activity assays to compare the ribonucleoprotein (RNP) assembly and activity properties of disease-linked subunit variants in holoenzyme context. Analysis of a large panel of hTR variants revealed numerous biochemical mechanisms for telomerase loss of function, including reduced association of hTR with TERT, reduced RNP catalytic activity, or loss in fidelity of telomeric repeat synthesis. An absolute correlation exists between hTR loss of function and hematopoietic deficiency, but there is no readily apparent telomerase deficiency imposed by an hTR variant linked to pulmonary fibrosis. Some disease-linked TERT variants have altered properties of holoenzyme assembly or repeat addition processivity, but other TERT variants linked to either pulmonary fibrosis or hematopoietic deficiency retained normal hTR interaction and RNP catalytic activity. Combined with additional hTR structure/function studies, our results establish a new resolution of insight into hTR structural requirements for hTR-TERT interaction and for the catalytic cycle of human telomerase holoenzyme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20022961      PMCID: PMC2836042          DOI: 10.1074/jbc.M109.088575

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Secondary structure of vertebrate telomerase RNA.

Authors:  J L Chen; M A Blasco; C W Greider
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

Review 2.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

3.  Distinct biogenesis pathways for human telomerase RNA and H/ACA small nucleolar RNAs.

Authors:  Dragony Fu; Kathleen Collins
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

4.  Human telomerase RNA mutations and bone marrow failure.

Authors:  David B Wilson; Jennifer Ivanovich; Alison Whelan; Paul J Goodfellow; Monica Bessler
Journal:  Lancet       Date:  2003-06-07       Impact factor: 79.321

5.  Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.

Authors:  Hiroki Yamaguchi; Gabriela M Baerlocher; Peter M Lansdorp; Stephen J Chanock; Olga Nunez; Elaine Sloand; Neal S Young
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

6.  A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA.

Authors:  Jiunn-Liang Chen; Kay Keyer Opperman; Carol W Greider
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

7.  The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.

Authors:  T Vulliamy; A Marrone; F Goldman; A Dearlove; M Bessler; P J Mason; I Dokal
Journal:  Nature       Date:  2001-09-27       Impact factor: 49.962

Review 8.  Telomerase in the human organism.

Authors:  Kathleen Collins; James R Mitchell
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

Review 9.  Syndromes of telomere shortening.

Authors:  Mary Armanios
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

10.  Association between aplastic anaemia and mutations in telomerase RNA.

Authors:  Tom Vulliamy; Anna Marrone; Inderjeet Dokal; Philip J Mason
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

View more
  48 in total

1.  Human telomerase domain interactions capture DNA for TEN domain-dependent processive elongation.

Authors:  Aaron R Robart; Kathleen Collins
Journal:  Mol Cell       Date:  2011-04-21       Impact factor: 17.970

2.  Structure of the Shq1-Cbf5-Nop10-Gar1 complex and implications for H/ACA RNP biogenesis and dyskeratosis congenita.

Authors:  Shuang Li; Jingqi Duan; Dandan Li; Shoucai Ma; Keqiong Ye
Journal:  EMBO J       Date:  2011-11-25       Impact factor: 11.598

3.  Structurally conserved five nucleotide bulge determines the overall topology of the core domain of human telomerase RNA.

Authors:  Qi Zhang; Nak-Kyoon Kim; Robert D Peterson; Zhonghua Wang; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-21       Impact factor: 11.205

4.  The 5' guanosine tracts of human telomerase RNA are recognized by the G-quadruplex binding domain of the RNA helicase DHX36 and function to increase RNA accumulation.

Authors:  Alec N Sexton; Kathleen Collins
Journal:  Mol Cell Biol       Date:  2010-12-13       Impact factor: 4.272

Review 5.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

Review 6.  Telomerase Mechanism of Telomere Synthesis.

Authors:  R Alex Wu; Heather E Upton; Jacob M Vogan; Kathleen Collins
Journal:  Annu Rev Biochem       Date:  2017-01-30       Impact factor: 23.643

7.  Architecture of human telomerase RNA.

Authors:  Qi Zhang; Nak-Kyoon Kim; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

8.  An antiapoptotic role for telomerase RNA in human immune cells independent of telomere integrity or telomerase enzymatic activity.

Authors:  Francesca S Gazzaniga; Elizabeth H Blackburn
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

9.  A homozygous telomerase T-motif variant resulting in markedly reduced repeat addition processivity in siblings with Hoyeraal Hreidarsson syndrome.

Authors:  Maria M Gramatges; Xiaodong Qi; Ghadir S Sasa; Julian J-L Chen; Alison A Bertuch
Journal:  Blood       Date:  2013-03-28       Impact factor: 22.113

Review 10.  InTERTpreting telomerase structure and function.

Authors:  Haley D M Wyatt; Stephen C West; Tara L Beattie
Journal:  Nucleic Acids Res       Date:  2010-05-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.